Dermatology Eczema

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Eczema Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Eczema Projects
--Alfresa Pharma Corporation
--Aerovance, Inc.
--AnGes MG, Inc.
--Anacor Pharmaceuticals, Inc.
--Arriva Pharmaceuticals, Inc
--Arachnova Limited
--Basilea Pharmaceutica AG
--Astion Pharma A/S
--Dong-A Pharmaceutical Co., Ltd.
--Biofrontera AG
--GlaxoSmithKline plc
--elbion NV
--LEO Pharma A/S
--JadoLabs GmbH
--Novartis AG
--Ligand Pharmaceuticals Inc
--REVOTAR Biopharmaceuticals AG
--PALAU PHARMA
--YORK PHARMA PLC
--Viralytics Ltd
--erly Psiron Ltd)

--Top Companies in early stage Eczema Projects
--Advitech inc.
--Action Pharma A/S
--Barrier Therapeutics Inc
--Astralis Ltd
--Enhance Biotech Inc
--DMI BioSciences, Inc.
--Indigene Pharmaceuticals, Inc.
--Hunter-Fleming Ltd
--Institute of Medicinal Molecular Design, Inc.
--Inotek Pharmaceuticals, Inc
--Melior Discovery, Inc.
--Manhattan Pharmaceuticals Inc.
--Novo-Nordisk A/S
--Merck Serono S.A.
--Shionogi & Co., Ltd.
--Serentis Ltd

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View